Haemonetics develops blood- and plasma-management technologies for hospitals, blood centers and plasma collectors. Its portfolio includes apheresis systems, software and consumables used in transfusion medicine, plasma collection and surgical blood management. The company sits at the intersection of medical devices and workflow software for blood supply chains.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 330.6 | — | 58 | — |
| Q2 2025 | 321.4 | — | 34 | — |
| Q3 2025 | 327.3 | — | 38.7 | — |
| Q4 2025 | 339 | — | 44.7 | — |
| Q1 2026 | 346.4 | 4.8% | -20.1 | -134.8% |
| Q2 2026 | 339.4 | 5.6% | 33 | -3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: ESAB Corporation (ESAB), MDA Space Ltd. (MDA), Vishay Intertechnology, Inc. (VSH), Tutor Perini Corporation (TPC), Trex Company, Inc. (TREX), Robert Half Inc. (RHI)